Eckert & Ziegler Strahlen- Und Medizintechnik AG (ETR:EUZ) | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Headlines Articles Press releases Eckert & Ziegler Strahlen- Und Medizintechnik AG

Home
Companies
Eckert & Ziegler Strahlen- Und Medizintechnik AG

BRIEF

published on 12/03/2025 at 09:05, 1 day 22 hours ago

Eckert & Ziegler and SK Biopharmaceuticals Form Actinium-225 Partnership

Oncology Eckert & Ziegler Radiopharmaceuticals Actinium-225 SK Biopharmaceuticals
PRESS RELEASE

published on 12/03/2025 at 09:00, 1 day 22 hours ago

Eckert & Ziegler and SK Biopharmaceuticals Sign Actinium-225 Supply Agreement
Eckert & Ziegler and SK Biopharmaceuticals sign Actinium-225 supply agreement for cancer therapies. Eckert & Ziegler to supply Ac-225 to accelerate SK Biopharmaceuticals' research and development activities in radiopharmaceutical therapies

Eckert & Ziegler Supply Agreement Actinium-225 Cancer Therapies SK Biopharmaceuticals
BRIEF

published on 11/13/2025 at 07:50, 21 days 23 hours ago

Eckert & Ziegler Reports Earnings and Sales Growth in 2025

Net Income Sales Increase Earnings Growth Medical Segment 2025 Forecast
PRESS RELEASE

published on 11/13/2025 at 07:45, 21 days 23 hours ago

Eckert & Ziegler Achieves Further Earnings Growth and Double-Digit Sales Growth in the Medical Segment
Eckert & Ziegler SE reports double-digit sales growth in the medical segment, with net income rising in the 3rd quarter of 2025. Strong performance outlook for 2025

Financial Results Sales Growth Eckert & Ziegler SE Medical Segment 2025 Forecast
BRIEF

published on 09/19/2025 at 12:05, 2 months 15 days ago

Eckert & Ziegler Receives Approval for GalliaPharm® in Japan

Regulatory Approval Nuclear Medicine Japan Market GalliaPharm® Isotope Technology
PRESS RELEASE

published on 09/19/2025 at 12:00, 2 months 15 days ago

Eckert & Ziegler Gains Approval for GalliaPharm® in Japan
Eckert & Ziegler obtains marketing approval in Japan for GalliaPharm® 68Ge/68Ga Radionuclide Generator, expanding access to Gallium-68 diagnostics and supporting precision imaging in healthcare

Eckert & Ziegler Regulatory Approval Japan Nuclear Medicine GalliaPharm
BRIEF

published on 09/09/2025 at 11:35, 2 months 25 days ago

Berenberg Initiates 'Buy' Rating for Eckert & Ziegler with Significant Upside

Buy Recommendation Eckert & Ziegler Price Target Nuclear Medicine Berenberg
PRESS RELEASE

published on 09/09/2025 at 11:30, 2 months 25 days ago

Eckert & Ziegler: Berenberg Starts Coverage with a “Buy” Recommendation and a Price Target of € 24 – Price Potential 47%
Berenberg initiates coverage on Eckert & Ziegler SE with a "Buy" recommendation and €24 price target, highlighting market position and rising demand for radioisotopes in nuclear medicine

Buy Recommendation Eckert & Ziegler SE Nuclear Medicine Berenberg Radioisotopes
BRIEF

published on 08/08/2025 at 07:50, 3 months 27 days ago

Eckert & Ziegler Reports Earnings Growth in First Half of 2025

Financial Results Profit Growth Medical Segment Isotope Products 2025 Forecast
PRESS RELEASE

published on 08/08/2025 at 07:45, 3 months 27 days ago

Eckert & Ziegler: Further Increase in Earnings in the First Half of 2025
Eckert & Ziegler SE reports a further increase in earnings in the first half of 2025, with sales of €148.8 million and net income of €21.4 million. Confirmed forecast for 2025: sales around €320 million and EBIT around €78 million

Sales Increase Earnings Eckert & Ziegler SE Medical Segment 2025 Forecast

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 33 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 4 hours 38 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 8 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 3 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 8 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 3 hours 37 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 17 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 42 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 53 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 57 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 13 hours 8 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 23 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 23 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE